Prospective Non-interventional Evaluation of Intubation and Intensive Care Use of the New aScope™ 4 Broncho and aView
NCT ID: NCT03294213
Last Updated: 2021-03-03
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
176 participants
OBSERVATIONAL
2017-09-25
2018-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this study is to obtain a broad user perspective of the aScope™ 4 Broncho, focusing on the device functionalities within regular clinical practice and therapeutic use of flexible bronchoscopes in the OR and ICU.
The study will include a minimum of 100 adult patients admitted to the operating room (OR) or Intensive Care Unit (ICU) undergoing at least one bronchoscopy procedure. The inclusion will stop when 100 fully evaluable patients or a maximum of 150 patients have been enrolled.
The involved sites will include patients during a five months' period, from September 2017 to January 2018.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Classification and Prediction of Difficult Awake Tracheal Intubation With Flexible Bronchoscopes
NCT06953414
Awake Tracheal Intubation in Critical Care Patients
NCT05802316
Intubation Assist Clinical Study
NCT03301324
"TRAcheostomy With Single Use Bronchoscopes vs. Conventional Bronchoscopes"
NCT03952247
Evaluation of the Ambu ® aScope® for Tracheal Intubation in Difficult Airways
NCT01467739
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
aScope 4 Broncho
The only data to be obtained are evaluation forms directly related to the users' perception of the aScope™ 4 Broncho
aScope 4 Broncho
Investigator is asked: "In your memory, compare your daily bronchoscope and the aScope 4 Broncho just evaluated" on patients admitted to the OR or ICU undergoing at least one bronchoscopy procedure Patients will not be asked to consent to participate in this study, as no patient data are obtained and the CE-marked aScope™ 4 Broncho is used within its intended use
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
aScope 4 Broncho
Investigator is asked: "In your memory, compare your daily bronchoscope and the aScope 4 Broncho just evaluated" on patients admitted to the OR or ICU undergoing at least one bronchoscopy procedure Patients will not be asked to consent to participate in this study, as no patient data are obtained and the CE-marked aScope™ 4 Broncho is used within its intended use
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinical indication and eligible for an airway procedure involving a bronchoscopy procedure, as judged by the Investigator
* Patients being admitted in the OR or ICU at the investigational site
Exclusion Criteria
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ambu A/S
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pia Nordmand, MSc
Role: STUDY_CHAIR
Ambu A/S
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Klinik für Anästhesiologie, Universitätsmedizin Mainz
Mainz, Rhineland-Palatinate, Germany
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CIS-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.